These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 7224706)
21. The effect of ageing on the hepatic clearance of propranolol. Castleden CM; George CF Br J Clin Pharmacol; 1979 Jan; 7(1):49-54. PubMed ID: 760742 [TBL] [Abstract][Full Text] [Related]
22. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition. Lo MW; Effeney DJ; Pond SM; Silber BM; Riegelman S J Pharmacol Exp Ther; 1982 May; 221(2):512-5. PubMed ID: 7077541 [TBL] [Abstract][Full Text] [Related]
23. Absorption kinetics of sublingually administered propranolol. Kates RE J Med; 1977; 8(6):393-402. PubMed ID: 272433 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog. Karim A; Kook C; Novotney RL; Zagarella J; Campion J Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556 [TBL] [Abstract][Full Text] [Related]
26. Stereochemistry of the in vivo disposition and metabolism of propranolol in dog and man using deuterium-labeled pseudoracemates. Walle T Drug Metab Dispos; 1985; 13(3):279-82. PubMed ID: 2861983 [No Abstract] [Full Text] [Related]
27. Phencyclidine (PCP) disposition kinetics in dogs as a function of dose and route of administration. Woodworth JR; Owens SM; Mayersohn M J Pharmacol Exp Ther; 1985 Sep; 234(3):654-61. PubMed ID: 4032285 [TBL] [Abstract][Full Text] [Related]
28. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing. Lankford SM; Maskasame C; Bai SA Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of N-nitrosodimethylamine in beagles. Gombar CT; Pylypiw HM; Harrington GW Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224 [TBL] [Abstract][Full Text] [Related]
30. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
31. Disposition of salmeterol xinafoate in laboratory animals and humans. Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of bromhexine in the dog. Vandecasteele-Thienpont LM; Belpaire FM; Braeckman RA; De Leenheer AP Arzneimittelforschung; 1980; 30(10):1643-5. PubMed ID: 7192102 [TBL] [Abstract][Full Text] [Related]